Molecular Dynamics and Amersham link up with cancer institute
This article was originally published in Clinica
Executive Summary
Molecular Dynamics and Amersham Life Science have formed an agreement with the US Huntsman Cancer Institute to enhance the performance of microarray technologies in complex biological systems. The institute will provide funding in exchange for early access to the two companies' latest microarray technologies, including instruments, reagents and consumables, technical support and training services.